1. Home
  2. MDGL vs ADT Comparison

MDGL vs ADT Comparison

Compare MDGL & ADT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • ADT
  • Stock Information
  • Founded
  • MDGL 2011
  • ADT 1874
  • Country
  • MDGL United States
  • ADT United States
  • Employees
  • MDGL N/A
  • ADT N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • ADT Diversified Commercial Services
  • Sector
  • MDGL Health Care
  • ADT Consumer Discretionary
  • Exchange
  • MDGL Nasdaq
  • ADT Nasdaq
  • Market Cap
  • MDGL 6.1B
  • ADT 7.0B
  • IPO Year
  • MDGL N/A
  • ADT 2018
  • Fundamental
  • Price
  • MDGL $425.60
  • ADT $8.77
  • Analyst Decision
  • MDGL Strong Buy
  • ADT Buy
  • Analyst Count
  • MDGL 10
  • ADT 5
  • Target Price
  • MDGL $474.67
  • ADT $9.34
  • AVG Volume (30 Days)
  • MDGL 377.9K
  • ADT 9.5M
  • Earning Date
  • MDGL 10-30-2025
  • ADT 10-23-2025
  • Dividend Yield
  • MDGL N/A
  • ADT 2.50%
  • EPS Growth
  • MDGL N/A
  • ADT N/A
  • EPS
  • MDGL N/A
  • ADT 0.68
  • Revenue
  • MDGL $515,547,000.00
  • ADT $5,058,741,000.00
  • Revenue This Year
  • MDGL $394.12
  • ADT $6.18
  • Revenue Next Year
  • MDGL $57.74
  • ADT $4.23
  • P/E Ratio
  • MDGL N/A
  • ADT $12.94
  • Revenue Growth
  • MDGL 3421.98
  • ADT 6.58
  • 52 Week Low
  • MDGL $200.63
  • ADT $6.68
  • 52 Week High
  • MDGL $457.16
  • ADT $8.93
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 58.97
  • ADT 54.45
  • Support Level
  • MDGL $425.00
  • ADT $8.52
  • Resistance Level
  • MDGL $440.90
  • ADT $8.89
  • Average True Range (ATR)
  • MDGL 14.19
  • ADT 0.15
  • MACD
  • MDGL -4.00
  • ADT 0.00
  • Stochastic Oscillator
  • MDGL 29.82
  • ADT 58.64

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About ADT ADT Inc.

ADT Inc is a provider of security, interactive, and smart home solutions serving consumer and small business customers in the United States (U.S.). The Company conducts business under the ADT brand name. The company segments include Consumer and Small Business (CSB).

Share on Social Networks: